AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation-Reference-Cited by-同舟云学术

AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation

Published:2017-06-23 Issue:4 Volume:58 Page:1043-1063
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Ivachtchenko Alexandre V.¹²,Okun Ilya³,Aladinskiy Vladimir⁴,Ivanenkov Yan⁴⁵,Koryakova Angela⁶,Karapetyan Ruben⁶,Mitkin Oleg⁶,Salimov Ramiz⁷,Ivashchenko Andrey⁶

Affiliation:

1. Alla Chem LLC, Hallandale Beach, FL, USA

2. Avineuro Pharmaceuticals, Inc., HallandaleBeach, FL, USA

3. ChemDiv Inc (Retired), SanDiego, CA, USA

4. Moscow Institute of Physics and Technology(State University), Dolgoprudny, Moscow Region, RussianFederation

5. Department of Chemistry, Moscow State University, Moscow, Russian Federation

6. Chemical Diversity Research Institute, Khimki, Moscow Region, Russian Federation

7. Currently at Incuron LLC, Moscow, Russia

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference62 articles.

1. AVN-101: A multitarget drug candidate for the treatment of CNS disorders;Ivachtchenko;J Alzheimers Dis,2016

2. Serotonin 5-HT6 receptorantagonists for the treatment of cognitive deficiency in Alzheimerdisease;Benhamú;J Med Chem,2014

3. Serotonin_6 receptors in the dorsal hippocampus regulatedepressive-like behaviors in unilateral 6-hydroxydopamine-lesionedParkinson’s rats;Liu;Neuropharmacology,2015

4. The precognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia;Nikiforuk;Rev Neurosci,2014

5. 5-HT6 receptors and Alzheimer disease;Ramírez;Alzheimer Res Ther,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of 5-HT6 Receptor Subcellular Localization on Its Signaling and Its Pathophysiological Roles;Cells;2023-01-27

2. Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice;Pharmaceuticals;2023-01-24

3. The 5-HT6R agonist E-6837 and the antagonist SB-271046 reverse the psychotic-like behaviors induced by ketamine;Behavioural Pharmacology;2022-02-04

4. Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments;International Journal of Molecular Sciences;2021-09-14

5. Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States;Journal of Medicinal Chemistry;2021-01-13